Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating carboplatin, paclitaxel, and surgery for advanced ovarian epithelial, fallopian tube, or primary peritoneal cancer;…
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) [Phase 2]
Phase 2 trial FOCUS evaluated dalteparin (Fragmin) for potential survival benefit in ovarian cancer; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema
Completed clinical trial evaluating a gynecologic cancer lymphedema questionnaire as a tool to identify lower-extremity lymphedema in patien…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer [Phase 2]
Phase 2 trial evaluating fondaparinux to prevent blood clots in patients undergoing surgery for gynecologic cancer has completed with result…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function [Phase 1]
Phase 1 trial assessing safety and dosage of docetaxel in patients with solid tumors and abnormal liver function. The study includes breast …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Evaluating Tools for Health Promotion and Disease Prevention [Phase 1]
This clinical trial update notes the completion of a Phase 1 study sponsored by the CDC evaluating tools for health promotion and disease pr…
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer [Phase 1]
A Phase 1 trial evaluated the maximum tolerated dose of lapatinib in combination with carboplatin for recurrent ovarian cancer. The study ha…
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer [Phase 2]
Phase 2 study funded by GlaxoSmithKline evaluating a second-line therapy for potentially platinum-sensitive relapsed ovarian cancer; results…
-
CLINICAL_TRIALS research · 2009-11-13Clinical Trial Update: Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers
A completed clinical trial from Memorial Sloan Kettering studied how common paraneoplastic autoantibodies are across several cancers and whe…
-
CLINICAL_TRIALS trial_result · 2009-10-29Clinical Trial Update: Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer [Phase 2]
A Phase 2 study assessing the effectiveness and safety of sequential cisplatin and docetaxel chemotherapy in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers [Phase 2]
A Phase 2 study evaluating an immune response modifier for breast, ovarian, endometrial, and cervical cancers has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors [Phase 1]
Phase 1 trial comparing oral picoplatin with intravenous picoplatin in patients with solid tumors has been completed, evaluating safety and …
-
CLINICAL_TRIALS trial_result · 2009-08-24Clinical Trial Update: A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 study of single-agent pemetrexed disodium in patients with recurrent or persistent ovarian cancer or primary peritoneal cancer; resu…
-
CLINICAL_TRIALS research · 2009-07-29Clinical Trial Update: Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer [Phase 2]
This is a Phase 2 clinical trial update evaluating whether nutritional supplements can improve quality of life during first-line chemotherap…
-
CLINICAL_TRIALS trial_result · 2009-07-20Clinical Trial Update: Genetic Studies in Breast Cancer
An update on genetic studies related to breast cancer (with ovarian cancer as a listed condition) from Memorial Sloan Kettering Cancer Cente…
-
CLINICAL_TRIALS withdrawal · 2009-07-14Clinical Trial Update: Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens [Phase 2]
Phase 2 trial of Velcade (bortezomib) in combination with CAELYX (pegylated liposomal doxorubicin) for ovarian cancer patients who failed pl…
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer [Phase 2]
Phase 2 trial update showing safety and preliminary efficacy of S-8184 as second-line therapy for stage III/IV ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial of docetaxel and capecitabine in recurrent or persistent ovarian epithelial cancer, fallopian tube cancer, and peritoneal canc…
-
CLINICAL_TRIALS trial_result · 2009-04-30Clinical Trial Update: Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer [Phase 2]
Phase 2 clinical trial evaluating whole-body hyperthermia in combination with chemotherapy for metastatic breast, ovarian, endometrial, or c…
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating the combination of topotecan and lapatinib in patients with early recurrent ovarian or peritoneal cancer has been…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer [Phase 1]
Phase 1 study evaluating motexafin gadolinium in combination with docetaxel for advanced cancers; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: Gemcitabine in Ovarian Cancer [Phase 2]
A Phase 2 clinical trial of gemcitabine for ovarian cancer has completed, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-03-03Clinical Trial Update: Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers [Phase 1]
Phase 1 trial evaluating the safety and immunogenicity of CHP-HER2 and CHP-NY-ESO-1 protein vaccines with OK-432 in patients with antigen-ex…
-
CLINICAL_TRIALS research · 2009-03-03Clinical Trial Update: The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between Clinical Prognosis and Regulatory T Cell Expression [NA]
A clinical trial update from National Taiwan University Hospital investigating the role of regulatory T cells in ovarian cancer and how thei…
-
CLINICAL_TRIALS research · 2009-03-03Clinical Trial Update: Screening and Identification of Ovarian Cancers [NA]
This clinical trial update covers screening and identification of ovarian cancers conducted by National Taiwan University Hospital.